Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (1501 total)
-
Creator:
Iqbal, Sara N., Rachael Overcash, Neggin Mokhtari, Haleema Saeed, Stacey Gold, Tamika Auguste, Muhammad-Usman Mirza, Maria-Elena Ruiz, Joeffrey J. Chahine, Masashi Waga, and Glenn Wortmann.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-04-16
Description: To rapidly communicate information on the global clinical effort against Covid-19, the Journal has initiated a series of case reports that offer important teaching points or novel findings. The case reports should be viewed as observations rather… -
Creator: Anne L. O'Keefe, Bryan F. Buss, Samir Koirala, Michael X. Gleason, Ashok Mudgapalli, and Shelly Schwedhelm.
Subject: Personnel Management
Item Type: Publication
Date Last Updated: 2019-02-19
Description: The Ebola epidemic of 2014 demonstrated that outbreaks of high-consequence infectious diseases, even in remote parts of the world, can affect communities anywhere in the developed world and that every healthcare facility must be prepared to identify,… -
Creator: National Institute of Allergy and Infectious Diseases (NIAID)
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2020-03-30
Description: This is a phase I, open-label, dose ranging clinical trial in males and non-pregnant females, 18 to 55 years of age, inclusive, who are in good health and meet all eligibility criteria. This clinical trial is designed to assess the safety,… -
Creator: National Institute of Allergy and Infectious Diseases (NIAID)
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2020-05-07
Description: This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in… -
Creator: Abigail E Lowe, Colleen Kraft, Mark G Kortepeter, Keith F Hansen, Kristine Sanger, Ann Johnson, Jonathan D Grein, Julie Martin, Rebecca Rousselle, Jennifer A Garland, Jessica Spotts, John J Lowe, Lauren M Sauer, Christopher J Kratochvil, Bruce G…
Subject: Research
Item Type: Publication
Date Last Updated: 2022-05-31
Description: Research is foundational for evidence-based management of patients. Clinical research, however, takes time to plan, conduct, and disseminate—a luxury that is rarely available during a public health emergency. The University of Nebraska Medical Center… -
Creator: Ackermann, Maximilian, Stijn E. Verleden, Mark Kuehnel, Axel Haverich, Tobias Welte, Florian Laenger, Arno Vanstapel, Christopher Werlein, Helge Stark, Alexandar Tzankov, William W. Li, Vincent W. Li, Steven J. Mentzer, and Danny Jonigk.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-07-09
Description: Progressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of the disease, relatively little is known about the associated morphologic and… -
Creator: Active Learning Network for Accountability and Performance in Humanitarian Action
Subject: Emergency Management
Item Type: Publication
Date Last Updated: 2017-06-26
Description: In November 2014, ALNAP launched a sub-group of the Urban Response Community of Practice (CoP) to gather learning from the urban aspects of the Ebola Virus Disease (EVD) response in West Africa. -
Creator: Active Learning Network for Accountability and Performance in Humanitarian Action
Subject: Emergency Management
Item Type: Publication
Date Last Updated: 2017-06-01
Description: This Working Paper explores the topic of working with urban populations and communities. -
Creator: ACTT- Study Group
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2022-05-23
Description: Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone plus remdesivir in preventing progression to… -
Creator: Adelman, M. W., D. R. Bhamidipati, A. C. Hernandez-Romieu, A. Babiker, M. H. Woodworth, C. Robichaux, D. J. Murphy, S. C. Auld, C. S. Kraft, and J. T. Jacob.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-06
Description: Hospitalized patients, particularly those who are critically ill, are at risk for ‘secondary’ infections(1, 2). Initial reports of patients hospitalized with COVID-19 indicate that 10-33% develop bacterial pneumonia(3, 4) and 2-6% develop bloodstream…